至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

UV-Inactivated rVSV-M2e-Based Influenza Vaccine Protected against the H1N1 Influenza Challenge

Front Biosci (Landmark Ed). 2024-05; 
Titus Abiola Olukitibi, Zhujun Ao, Hiva Azizi, Maggie J Ouyang, Tosin Omole, Lyle McKinnon, Darwyn Kobasa, Kevin Coombs, Gary Kobinger, Xiaojian Yao
Products/Services Used Details Operation
Molecular Biology Reagents GenScript (Piscataway, NJ, USA) using the methods described previously [27]. The Western Blot (WB) detection enhanced chemiluminescence (ECL) kit was obtained from PerkinElmer … Get A Quote

摘要

background: To investigate the immune responses and protection ability of ultraviolet light (UV)-inactivated recombinant vesicular stomatitis (rVSV)-based vectors that expressed a fusion protein consisting of four copies of the influenza matrix 2 protein ectodomain (tM2e) and the Dendritic Cell (DC)-targeting domain of the Ebola Glycoprotein (EΔM), (rVSV-EΔM-tM2e). methods: In our previous study, we demonstrated the effectiveness of rVSV-EΔM-tM2e to induce robust immune responses against influenza M2e and protect against lethal challenges from H1N1 and H3N2 strains. Here, we used UV to inactivate rVSV-EΔM-tM2e and tested its immunogenicity and protection in BALB/c mice from a mouse-adapted H1N1 influenza ch... More

关键词

Antibody-Dependent Cellular Cytotoxicity (ADCC), Ebola glycoprotein, M2 ectodomain, UV-inactivation, influenza, recombinant vesicular stomatitis virus